These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 23348899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes.
    Kochi M, Fujii M, Masuda S, Kanamori N, Mihara Y, Funada T, Tamegai H, Watanabe M, Suda H, Takayama T.
    Diagn Pathol; 2013 Nov 21; 8():191. PubMed ID: 24261710
    [Abstract] [Full Text] [Related]

  • 5. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.
    Qin R, Wang NN, Chu J, Wang X.
    World J Gastroenterol; 2012 Jul 07; 18(25):3296-302. PubMed ID: 22783055
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
    Bozzetti C, Negri FV, Lagrasta CA, Crafa P, Bassano C, Tamagnini I, Gardini G, Nizzoli R, Leonardi F, Gasparro D, Camisa R, Cavalli S, Silini EM, Ardizzoni A.
    Br J Cancer; 2011 Apr 26; 104(9):1372-6. PubMed ID: 21487407
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
    Nishida Y, Kuwata T, Nitta H, Dennis E, Aizawa M, Kinoshita T, Ohtsu A, Ochiai A.
    Gastric Cancer; 2015 Jul 26; 18(3):458-66. PubMed ID: 24917219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma.
    Wang YK, Chen Z, Yun T, Li CY, Jiang B, Lv XX, Chu GH, Wang SN, Yan H, Shi LF.
    World J Gastroenterol; 2015 Apr 21; 21(15):4680-7. PubMed ID: 25914479
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HER2 status in unusual histological variants of gastric adenocarcinomas.
    Giuffrè G, Ieni A, Barresi V, Caruso RA, Tuccari G.
    J Clin Pathol; 2012 Mar 21; 65(3):237-41. PubMed ID: 22067088
    [Abstract] [Full Text] [Related]

  • 18. Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization.
    Vogel UF.
    Diagn Pathol; 2010 Jul 29; 5():50. PubMed ID: 20670419
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.